Portfolio P&L Dashboard

Live pricing impact across all active deals — Q2 FY2026

Updated 09:18 AM

Live

3 deals below margin threshold — gross margin under 40% or negative net margin detected.

Total Portfolio Revenue

$4,045,440

+4.2%vs. prior period

Across 13 active deals

Wtd. Avg Gross Margin

56.7%

-1.8%vs. prior period

Portfolio-weighted by deal revenue

Total Net Profit

$1,082,105

+2.1%vs. prior period

After COGS, OpEx, and overhead

At-Risk Deals

3deals

Below 40% gross margin or negative net

Price Realization

88.5%

-2.4%discount erosion

Net price ÷ list price across portfolio

P&L Sensitivity

Net profit impact per 1% price change

Portfolio Level

+1% Price

+$38.2K

+5% Price

+$191K

-5% Price

-$191K

Gross & Net Margin Trend

12-week rolling — all active deals

Last 12 Weeks

Revenue to net profit decomposition

YTD Q2

Ranked by net price — margin health at a glance

Deal	Customer	Net Price	Gross Margin	Net Margin	Status
Multi-Region Deployment	Axiom Pharma Ltd.	$729,800	50.0%	20.0%	Draft
Managed Services — 3yr	Northbridge Capital	$676,800	65.0%	35.0%	Approved
Cloud Migration Bundle	Vantage Logistics	$617,500	65.0%	35.0%	Approved
Legacy System Replacement	Irongate Manufacturing	$432,000	40.0%	10.0%	Under Review
Enterprise Platform — Tier 1	Northbridge Capital	$422,400	60.0%	30.0%	Under Review
Data Warehouse Pro	Solaris Energy APAC	$288,000	65.0%	35.0%	Modeled
Compliance Automation Suite	Crestview Financial	$254,800	65.0%	35.0%	Modeled
Analytics Suite — Annual	Meridian Health Group	$193,200	50.0%	20.0%	Modeled